Ftse Mib
34.825,01
-1,62%
DAX
18.768,96
0,33%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,65%
Bitcoin
71.296,12
-0,21%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cumberland Pharmaceutical Inc (CPIX) Cumberland Pharmaceutical Inc (CPIX) Notizie

CPIX

Cumberland Pharmaceutical (CPIX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CPIX
DataOraFonteTitoloSimboloCompagnia
10/05/202422:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CPIXCumberland Pharmaceutical Inc
07/05/202423:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
07/05/202422:05PR Newswire (US)Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company UpdateNASDAQ:CPIXCumberland Pharmaceutical Inc
30/04/202422:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
02/04/202422:05PR Newswire (US)NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONSNASDAQ:CPIXCumberland Pharmaceutical Inc
05/03/202422:05PR Newswire (US)Cumberland Pharmaceuticals Reports Annual 2023 Financial ResultsNASDAQ:CPIXCumberland Pharmaceutical Inc
27/02/202422:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
09/02/202423:27Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CPIXCumberland Pharmaceutical Inc
28/12/202323:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
27/12/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CPIXCumberland Pharmaceutical Inc
15/12/202322:14Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:CPIXCumberland Pharmaceutical Inc
14/12/202323:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CPIXCumberland Pharmaceutical Inc
06/12/202323:01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CPIXCumberland Pharmaceutical Inc
07/11/202322:05PR Newswire (US)Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:CPIXCumberland Pharmaceutical Inc
31/10/202321:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
10/10/202322:05PR Newswire (US)NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGENASDAQ:CPIXCumberland Pharmaceutical Inc
27/09/202316:55Dow Jones NewsCorrection to SEC Fines ArticleNASDAQ:CPIXCumberland Pharmaceutical Inc
27/09/202316:43Dow Jones NewsSEC Fines 5 Public Companies, Insiders Over Reporting FailuresNASDAQ:CPIXCumberland Pharmaceutical Inc
08/08/202322:05PR Newswire (US)Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023NASDAQ:CPIXCumberland Pharmaceutical Inc
01/08/202322:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
26/06/202315:00PR Newswire (US)NEW PUBLICATION SUPPORTS THE USE OF CALDOLOR® IN NEWBORN PEDIATRIC PATIENTSNASDAQ:CPIXCumberland Pharmaceutical Inc
22/06/202312:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CPIXCumberland Pharmaceutical Inc
23/05/202315:00PR Newswire (US)CUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND FOR NEW TREATMENT OF IDIOPATHIC PULMONARY FIBROSISNASDAQ:CPIXCumberland Pharmaceutical Inc
16/05/202323:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CPIXCumberland Pharmaceutical Inc
15/05/202315:00PR Newswire (US)CALDOLOR® NOW FDA APPROVED FOR TREATMENT OF FEVER & PAIN IN INFANTSNASDAQ:CPIXCumberland Pharmaceutical Inc
09/05/202322:05PR Newswire (US)Cumberland Pharmaceuticals Reports First Quarter 2023 Financial Results & Company UpdateNASDAQ:CPIXCumberland Pharmaceutical Inc
02/05/202322:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
27/03/202323:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPIXCumberland Pharmaceutical Inc
15/03/202312:41Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CPIXCumberland Pharmaceutical Inc
13/03/202322:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CPIXCumberland Pharmaceutical Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CPIX

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BPE
Bper Banca
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
TIT
Telecom Italia
BIT
BPSO
Banca Popolare di Sondrio
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
SPM
Saipem
BIT
G
Generali
BIT
BAMI
Banco BPM
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
TEN
Tenaris
BIT
TITR
Telecom Italia
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network